Eagle Pharmaceuticals has appointed Michael Moran, a seasoned sales executive in the pharmaceuticals industry, to the role of U.S. Head of Sales, effective immediately.
“Mike is an exceptional sales leader with a lengthy record of success in this industry, and we are very pleased to have him aboard,” said Scott Tarriff, President and Chief Executive Officer. “His extensive experience and innovative selling strategies will make him a valuable asset to Eagle as we continue to develop our sales capabilities, strengthening our market position as a fully commercial specialty company with a broad and growing portfolio. In particular, we expect to leverage his expertise to coordinate our co-promotional activities with Spectrum Pharmaceuticals, as we finalize building our 20 person internal sales force. Eagle will have about 50 people selling our products and Mike will be coordinating this activity on a national scale. His background makes him uniquely qualified to sell our in-market and forthcoming products, including Ryanodex, Bivalirudin, Docetaxel, and Bendeka, among others. We look forward to benefiting from his experience.”
Michael Moran is an industry veteran with more than 15 years of experience in pharmaceutical sales. Prior to joining Eagle he spent seven years in various leadership roles at GlaxoSmithKline, including most recently the role of field vice president, where he oversaw more than 100 sales representatives and increased key customer reach by 45%. His additional accomplishments at GlaxoSmithKline include successfully coordinating several product launches across a global footprint, and negotiating the acquisition or co-promotion of additional products. He has received numerous awards in recognition of his outstanding project leadership and sales achievements.
“Eagle is an impressive company with exciting prospects, and I am thrilled to be joining the team at this key moment in its growth story,” said Mr. Moran. “Eagle’s high-quality portfolio of unique products, combined with its robust drug pipeline, have positioned it to realize numerous selling opportunities in areas with strong unmet demand. I am eager to collaborate with the Company’s partners and our own internal team to achieve meaningful growth in sales. It is a pleasure to be working with Eagle on products that represent such a compelling potential to improve, and even save, the lives of patients. I look forward to helping the Company deliver these treatments to the people and organizations that need them.”
Mr. Moran earned his B.S. in Business Management from the State University of New York at Empire, and completed the Transformational Leadership for Executives program at the University of Pennsylvania Wharton School of Business.